|
CHM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.0263999999679E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.7664999999969E-05 |
| Normal-vs-Stage2 |
5.138900E-03 |
| Normal-vs-Stage3 |
1.35420000002551E-06 |
| Normal-vs-Stage4 |
1.32580000000715E-06 |
| Stage1-vs-Stage2 |
6.192600E-01 |
| Stage1-vs-Stage3 |
2.474200E-01 |
| Stage1-vs-Stage4 |
1.293950E-01 |
| Stage2-vs-Stage3 |
1.855560E-01 |
| Stage2-vs-Stage4 |
8.596000E-02 |
| Stage3-vs-Stage4 |
5.118400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65669999996343E-06 |
| Normal-vs-AfricanAmerican |
2.324800E-01 |
| Normal-vs-Asian |
2.458200E-03 |
| Caucasian-vs-AfricanAmerican |
5.571700E-02 |
| Caucasian-vs-Asian |
5.988000E-01 |
| AfricanAmerican-vs-Asian |
2.376800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.49369447103254E-11 |
| Normal-vs-Female |
3.812700E-04 |
| Male-vs-Female |
3.77649999999674E-05 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.991500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.31569999997738E-06 |
| Normal-vs-Age(61-80Yrs) |
1.165860E-04 |
| Normal-vs-Age(81-100Yrs) |
2.603000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.595800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.114800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.910000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.994600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.726400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.541600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.290300E-02 |
| Classical-VS-Follicular |
4.386800E-01 |
| Classical-VS-Other |
1.260400E-01 |
| Classical-VS-Normal |
1.638020E-04 |
| Tall-VS-Follicular |
3.756600E-01 |
| Tall-VS-Other |
3.143200E-01 |
| Tall-VS-Normal |
6.09799999999883E-05 |
| Follicular-VS-Other |
2.306000E-01 |
| Follicular-VS-Normal |
2.194200E-04 |
| Other-VS-Normal |
1.861170E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6949799999999E-05 |
| Normal-vs-N1 |
1.51615999999244E-05 |
| N0-vs-N1 |
2.819600E-01 |
|
|
